CRISPR Therapeutics AG (CRSP)
NASDAQ·Healthcare·Biotechnology
$52.15
+2.25%
Mkt Cap $4.68B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $4.72M | $864.00K | -81.69% | -$1.15 | -$1.37 | -19.13% | — | — |
| Q4 2025 Nov 10, 2025 | $9.12M | $889.00K | -90.25% | -$1.26 | -$1.17 | +7.14% | — | — |
| Q3 2025 Aug 4, 2025 | $9.44M | $892.00K | -90.55% | -$1.47 | -$1.29 | +12.24% | — | — |
| Q2 2025 May 6, 2025 | $5.96M | $865.00K | -85.50% | -$1.27 | -$1.58 | -24.41% | — | — |
| Q1 2025 Feb 11, 2025 | $8.06M | $35.00M | +334.51% | -$1.15 | -$0.44 | +61.74% | — | — |
| Q4 2024 Nov 5, 2024 | $7.70M | $602.00K | -92.18% | -$1.33 | -$1.01 | +24.06% | — | — |
| Q3 2024 Aug 5, 2024 | $16.57M | $517.00K | -96.88% | -$1.37 | -$1.49 | -8.76% | — | — |
| Q2 2024 May 8, 2024 | $3.54M | $504.00K | -85.76% | -$1.63 | -$1.43 | +12.27% | — | — |
| Q1 2024 Feb 21, 2024 | $28.11M | $200.00M | +611.49% | -$0.07 | $1.10 | +1671.43% | — | — |
| Q4 2023 Nov 6, 2023 | $7.96M | — | — | -$1.98 | -$1.41 | +28.79% | — | — |
| Q3 2023 Aug 7, 2023 | $1.71M | $70.00M | +3993.57% | -$2.18 | -$0.98 | +55.05% | — | — |
| Q2 2023 May 8, 2023 | $1.71M | $100.00M | +5747.95% | -$1.67 | -$0.67 | +59.88% | — | — |
| Q1 2023 Feb 21, 2023 | $22.98K | $6.00K | -73.89% | -$2.32 | -$1.41 | +39.22% | — | — |
| Q4 2022 Nov 1, 2022 | $1.85M | $94.00K | -94.91% | -$2.30 | -$2.24 | +2.61% | — | — |
| Q3 2022 Aug 8, 2022 | $2.21M | $158.00K | -92.86% | -$2.23 | -$2.40 | -7.62% | — | — |
| Q2 2022 May 9, 2022 | $2.80M | $178.00K | -93.64% | -$1.91 | -$2.32 | -21.47% | — | — |
| Q1 2022 Feb 15, 2022 | $2.19M | $12.35M | +465.05% | -$1.74 | -$1.84 | -5.75% | — | — |
| Q4 2021 Nov 3, 2021 | $833.75K | $329.00K | -60.54% | -$1.69 | -$1.67 | +1.18% | — | — |
| Q3 2021 Jul 29, 2021 | $845.94M | $900.20M | +6.41% | $3.52 | $9.44 | +168.18% | — | — |
| Q2 2021 Apr 27, 2021 | $1.21M | $202.00K | -83.31% | -$1.45 | -$1.51 | -4.14% | — | — |